Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Acta Dermato-Venereologica|June 27, 2022
A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with ErythrodermaCamille Luherne, Sarah Menguy, Thomas Ferte, et al.JAAD International|October 29, 2021
Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 therapies for melanoma: A cross-sectional studyLéa Dousset, Alize Pacaud, Thomas Barnetche, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|July 16, 2017
Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanomaMarine Rousset, Caroline Dutriaux, Pauline Bosco-Lévy, et al.Journal of Neurology|May 23, 2019
Myopathy and scleromyxedemaAntoine Soulages, Hoang Marie-Ange Tang, Anne Pham-Ledard, et al.Cancer Medicine|March 7, 2020
Reliable blood cancer cells' telomere length evaluation by qPCRJoana Ropio, Alain Chebly, Jacky Ferrer, et al.The Journal of Investigative Dermatology|August 15, 2022
Proliferative Tumor-Infiltrating Lymphocytes' Abundance within the Microenvironment Impacts Clinical Outcome in Cutaneous B-Cell LymphomasSarah Menguy, Martina Prochazkova-Carlotti, Lamia Azzi-Martin, et al.American Journal of Clinical Pathology|February 20, 2015
Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesionsAnne Pham-Ledard, Anne Cowppli-Bony, Adélaïde Doussau, et al.Plos One|April 22, 2022
Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profilingAudrey Gros, Sarah Menguy, Victor Bobée, et al.The Journal of Investigative Dermatology|June 1, 2019
Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg TypeOcéane Ducharme, Marie Beylot-Barry, Anne Pham-Ledard, et al.European Journal of Dermatology : EJD|May 20, 2017
Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patientsSaskia Ingen-Housz-Oro, Anne Pham-Ledard, Pauline Brice, et al.Pageof 6